Nestlé Health Science – How do HMO modulate the immune system in infants with CMPA? emerging evidence and clinical implications.
Friday 09 Jun, 14:30 PM -
15:30 PM CEST
Mechanisms of HMO in modulating immune response
Clinical implications of 2’FL and LNnT in the nutritional management of CMPA
Evolving our understanding of the impact of 2’FL and LNnT on the gut microbiome and metabolome in infants with CMPA